Clinical Trial Update: Impact of COX2 on Sera Biomarkers From Obese Subjects [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update investigating the impact of COX-2 on serum biomarkers in obese breast cancer survivors; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Breast Cancer Survivors | EARLY_Phase 1 | Status: COMPLETED